Phathom Pharmaceuticals, Inc. (PHAT)
NASDAQ: PHAT · Real-Time Price · USD
11.82
+0.18 (1.55%)
At close: Oct 10, 2025, 4:00 PM EDT
11.97
+0.15 (1.27%)
After-hours: Oct 10, 2025, 7:07 PM EDT

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023
Period Ending
Dec '24 Dec '23
Vonoprazan
55.25M
Log In
Vonoprazan Growth
8001.47%
Log In

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023
Period Ending
Dec '24 Dec '23
United States
55.25M
Log In
United States Growth
8001.47%
Log In